Outcomes on the Waiting List for Candidates Receiving an Angiotensin Receptor-Neprilysin Inhibitor at Listing

C. Jasseron,R. Dorent,O. Bastien, C. Legeai

JOURNAL OF HEART AND LUNG TRANSPLANTATION（2020）

引用 0|浏览23

暂无评分

摘要

Use of SV at listing is frequent in contemporary heart transplant candidates without circulatory support. Our findings suggest that SV use may be associated with reduced risk of waitlist mortality without effect on hospitalization rate.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要